Annual Cash & Cash Equivalents
$153.60 K
-$47.30 K-23.54%
December 31, 2022
Summary
- As of February 10, 2025, MTAC annual cash & cash equivalents is $153.60 thousand, with the most recent change of -$47.30 thousand (-23.54%) on December 31, 2022.
- During the last 3 years, MTAC annual cash & cash equivalents has fallen by -$1.18 million (-88.49%).
Performance
MTAC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$104.00 K
-$32.80 K-23.98%
June 30, 2023
Summary
- As of February 10, 2025, MTAC quarterly cash and cash equivalents is $104.00 thousand, with the most recent change of -$32.80 thousand (-23.98%) on June 30, 2023.
- Over the past year, MTAC quarterly cash and cash equivalents has increased by +$34.80 thousand (+50.29%).
Performance
MTAC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MTAC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.5% | +50.3% |
| 3 y3 years | -88.5% | +316.0% |
| 5 y5 years | -88.5% | +316.0% |
MTAC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.5% | at low | -49.9% | -51.1% |
| 5 y | 5-year | -88.5% | at low | -90.8% | -76.0% |
| alltime | all time | -88.5% | at low | -90.8% | -76.0% |
MedTech Acquisition Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $104.00 K(-24.0%) |
| Mar 2023 | - | $136.80 K(-10.9%) |
| Dec 2022 | $153.60 K(-23.5%) | $153.60 K(-26.0%) |
| Sep 2022 | - | $207.60 K(+200.0%) |
| Jun 2022 | - | $69.20 K(+36.0%) |
| Mar 2022 | - | $50.90 K(-74.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $200.90 K(-85.0%) | $200.90 K(-27.7%) |
| Sep 2021 | - | $277.80 K(-56.8%) |
| Jun 2021 | - | $642.90 K(-43.1%) |
| Mar 2021 | - | $1.13 M(+4416.8%) |
| Dec 2020 | $1.33 M | - |
| Sep 2020 | - | $25.00 K |
FAQ
- What is MedTech Acquisition annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MedTech Acquisition?
- What is MedTech Acquisition annual cash & cash equivalents year-on-year change?
- What is MedTech Acquisition quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MedTech Acquisition?
- What is MedTech Acquisition quarterly cash and cash equivalents year-on-year change?
What is MedTech Acquisition annual cash & cash equivalents?
The current annual cash & cash equivalents of MTAC is $153.60 K
What is the all time high annual cash & cash equivalents for MedTech Acquisition?
MedTech Acquisition all-time high annual cash & cash equivalents is $1.33 M
What is MedTech Acquisition annual cash & cash equivalents year-on-year change?
Over the past year, MTAC annual cash & cash equivalents has changed by -$47.30 K (-23.54%)
What is MedTech Acquisition quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MTAC is $104.00 K
What is the all time high quarterly cash and cash equivalents for MedTech Acquisition?
MedTech Acquisition all-time high quarterly cash and cash equivalents is $1.13 M
What is MedTech Acquisition quarterly cash and cash equivalents year-on-year change?
Over the past year, MTAC quarterly cash and cash equivalents has changed by +$34.80 K (+50.29%)